Streetbeat News

Partnerships

MRNA

Moderna, Inc. (NASDAQ:MRNA) shares traded higher after the company signed a memorandum of understanding and land collaboration agreement to research, develop and manufacture mRNA medicines in China. The agreement allows Moderna to develop drugs exclusively for the Chinese market. The company also announced global regulatory submissions for mRNA-1345, including the European Medicines Agency.

Portfolio Pulse from Ryan Gustafson

July 05, 2023 | 8:31 pm

VBIV

VBI Vaccines and Brii Biosciences have announced the expansion of their partnership on hepatitis B. This news has led to an increase in VBI Vaccines' share prices.

Portfolio Pulse from Bill Haddad

July 05, 2023 | 8:19 pm

AMZN

ROKT

UFO

Blue Origin, the aerospace manufacturer founded by Amazon's Executive Chairman Jeff Bezos, is planning to establish international launch sites as part of its global expansion strategy. This move follows the company's domestic progress, including partnerships with NASA and successful launches. The expansion could impact related companies like Amazon and SpaceX, as well as ETFs like the Procure Space ETF (NYSE:UFO) and the SPDR S&P Kensho Final Frontiers ETF (NYSE:ROKT).

Portfolio Pulse from Benzinga Newsbot

July 05, 2023 | 8:18 pm

HTCR

Software development company HeartCore Enterprises, Inc. (NASDAQ:HTCR) has signed a partnership agreement with digital marketing consultant INTRIX, Inc. to license its Content Management System (CMS). The CMS platform will be used by INTRIX to manage and distribute content. HeartCore's CMS has been used by over 680 Japanese companies for corporate content management.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:09 pm

JBLU

JetBlue has issued a statement disagreeing with the court's ruling against its Northeast Alliance (NEA) with American Airlines. The company believes the NEA has been successful in increasing capacity, adding new routes, reducing fares, and providing an alternative to Delta and United. The alliance has also expanded the value of JetBlue's loyalty program benefits.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 8:08 pm

ACT

Enact Holdings, Inc. (NASDAQ:ACT) has entered into a quota share reinsurance agreement, under which it will cede 13.125% of a portion of current and expected new insurance written for the period from January 1, 2023 through December 31, 2023. Since 2015, Enact has executed approximately $4.7 billion of Excess of Loss CRT transactions, including reinsurance coverage of approximately $2.9 billion with highly rated reinsurers.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:05 pm

VBIV

VBI Vaccines and Brii Biosciences have expanded their partnership to address both prevention and treatment of Hepatitis B. Brii Biosciences has acquired worldwide exclusive license to VBI-2601 and an exclusive license for PreHevbri® in the Asia Pacific region. VBI will receive $15 million in upfront payments, including a $3 million equity investment, and is eligible to receive up to $422 million in additional potential regulatory and commercial milestone payments, plus double-digit royalties.

Portfolio Pulse from Benzinga Newsdesk

July 05, 2023 | 8:02 pm

LDOS

Leidos (NYSE:LDOS) has been selected to provide pilot training for U.S. Army aviators transitioning to the High Accuracy Detection, Exploitation System (HADES) program. The company will provide ground and flight training through Bombardier Global 6000-class business jets, with FAA certified flight instructors, curriculum, support materials, and training manuals.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:01 pm

NKLA

Nikola Corporation (NASDAQ:NKLA) has been awarded a $41.9 million grant by the California Transportation Commission (CTC) to build six heavy-duty hydrogen refueling stations across Southern California. The grant is part of the Trade Corridor Enhancement Program (TCEP) and will be used to further Caltrans' zero-emission vehicle (ZEV) strategy. The stations are expected to facilitate refueling for approximately 80 to 100 trucks per station per day and are designed to scale up over time.

Portfolio Pulse from Happy Mohamed

July 05, 2023 | 8:01 pm

GSK

WVE

Raymond James has initiated coverage on WAVE Life Sciences Ltd (WVE) with a price target of $9 and an Outperform rating. The analyst believes that WAVE is leading in RNA editing with WVE-006 for Alpha-1 antitrypsin deficiency (AATD), being developed in collaboration with GSK Plc. The collaboration includes a discovery collaboration that allows GSK to advance up to eight programs and Wave to advance up to three programs. WVE shares are up 7.30% at $3.82.

Portfolio Pulse from Vandana Singh

July 05, 2023 | 7:47 pm